SEARCH RESULTS FOR: "Tag: SRPT"
loading image
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2024(1)
2023(1)
2021(1)
2019(12)
2018(7)
2017(14)
2016(28)
2015(7)
2014(2)
CATEGORIES
Analyst Downgrades(2)
Analyst Update(12)
Analyst Upgrades(8)
Best and Worst Stocks(2)
Buzz Stocks(12)
By the Numbers(2)
General(2)
Indexes and ETFs(2)
Intraday Option Activity(7)
Midday Market Check(9)
Most Active Options Update(1)
Most Active Weekly Options(1)
Opening View(10)
Quantitative Analysis(4)
Stock Market News(9)
Stocks On the Move(12)
Technical Analysis(2)
Unusual Trading Activity(1)

7/17/2024 2:35 PM
In June, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month. XBI proceeded to rattle off a 4% win for June and is up 7.3% in July already. Wh...
5/24/2023 10:53 AM
Sarepta Therapeutics Inc (NASDAQ:SRPT) is gaining some attention in the biotech realm today. The company is seeking accelerated approval from the U.S. Food & Drug Administration (FDA) for its gene the...
1/8/2021 10:07 AM
The shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) have nearly halved this morning, down 49.8% at $84.90 at last check, after the company's experimental gene therapy to treat Duchene muscular dystr...
12/23/2019 9:11 AM
Fresh off a record-setting week, Dow Jones Industrial Average (DJI) futures are trending higher yet again. Fueling this morning's risk-on approach are trade tailwinds out of China, after the countr...
12/16/2019 2:37 PM
The shares of pharmaceutical concern Wave Life Sciences Ltd (NASDAQ:WVE) have more than halved today after the firm said it would be halting the development of its Duchenne muscular distrophy (DMD) d...